TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Bioglan AB
Closing information (x1000 NOK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
306,622
|
228,470
|
171,411 |
| Financial expenses |
696
|
925
|
760 |
| Earnings before taxes |
40,614
|
30,080
|
10,011 |
| EBITDA |
44,917
|
37,452
|
15,546 |
| Total assets |
292,938
|
232,213
|
178,632 |
| Current assets |
197,174
|
150,573
|
115,206 |
| Current liabilities |
122,799
|
96,648
|
73,969 |
| Equity capital |
170,139
|
135,565
|
104,662 |
| - share capital |
3,094
|
3,039
|
2,838 |
| Employees (average) |
113
|
102
|
101 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
58.1%
|
58.4%
|
58.6% |
| Turnover per employee |
2,713
|
2,240
|
1,697 |
| Profit as a percentage of turnover |
13.2%
|
13.2%
|
5.8% |
| Return on assets (ROA) |
14.1%
|
13.4%
|
6.0% |
| Current ratio |
160.6%
|
155.8%
|
155.7% |
| Return on equity (ROE) |
23.9%
|
22.2%
|
9.6% |
| Change turnover |
74,033
|
44,897
|
18,805 |
| Change turnover % |
32%
|
24%
|
12% |
| Chg. No. of employees |
11
|
1
|
7 |
| Chg. No. of employees % |
11%
|
1%
|
7% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.